S O’Donnell et al

healing: A double-blind, randomized, controlled versus placebo
trial in 107 patients. Angiology 1997;48:77-85.
470. Coleridge-Smith P, Lok C, Ramelet AA. Venous leg ulcer: A metaanalysis of adjunctive therapy with micronized puriﬁed ﬂavonoid
fraction. Eur J Vasc Endovasc Surg 2005;30:198-208.
471. Guilhou JJ, Fevrier F, Debure C, Dubeaux D, Gillet-Terver MN,
Guillot B, et al. Beneﬁt of a 2-month treatment with a micronized,
puriﬁed ﬂavonoidic fraction on venous ulcer healing. A randomized,
double-blind, controlled versus placebo trial. Int J Microcirc Clin Exp
1997;17(Suppl 1):21-6.
472. Glinski W, Chodynicka B, Roszkiewicz J, et al. [Effectiveness of a
micronized puriﬁed ﬂavonoid fraction (MPFF) in the healing process
of lower limb ulcers. An open multicentre study, controlled and
randomized]. Minerva Cardioangiol 2001;49:107-14.
473. Smith PC. Daﬂon 500 mg and venous leg ulcer: New results from a
meta-analysis. Angiology 2005;56(Suppl 1):S33-9.
474. Gohel MS, Davies AH. Pharmacological treatment in patients with
C4, C5 and C6 venous disease. Phlebology 2010;25(Suppl 1):35-41.
475. Katsenis K. Micronized puriﬁed ﬂavonoid fraction (MPFF): A review
of its pharmacological effects, therapeutic efﬁcacy and beneﬁts in the
management of chronic venous insufﬁciency. Curr Vasc Pharmacol
2005;3:1-9.
476. Coler